Search Results | Clinical Cancer Research | American Association for Cancer Research

1-20 of 47

2 3

Sort by

Sort Order Select

Journal Articles

The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma

Smita Sihag, Samuel C. Nussenzweig, Henry S. Walch, Meier Hsu, Kay See Tan, Sergio De La Torre, Yelena Y. Janjigian, Steven B. Maron, Geoffrey Y. Ku, Laura H. Tang, Pari M. Shah, Abraham Wu, David R. Jones, David B. Solit, Nikolaus Schultz, Karuna Ganesh, Michael F. Berger, Daniela Molena

Clin Cancer Res OF1–OF10.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-4016

Published: 03 May 2022

View article

Includes: Supplementary data

Journal Articles

Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors

Clin Cancer Res (2022) 28 (2): 318–326.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-2577

Published: 19 January 2022

View article

Includes: Supplementary data

Journal Articles

Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer

Clin Cancer Res (2021) 27 (16): 4599–4609.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-0205

Published: 15 August 2021

View article

Includes: Supplementary data

Journal Articles

Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways

Clin Cancer Res (2021) 27 (12): 3491–3498.

DOI: https://doi.org/10.1158/1078-0432.CCR-20-4707

Published: 15 June 2021

View article

Includes: Supplementary data

Journal Articles

Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas

Clin Cancer Res (2021) 27 (8): 2226–2235.

DOI: https://doi.org/10.1158/1078-0432.CCR-20-4189

Published: 15 April 2021

View article

Includes: Supplementary data

Journal Articles

Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial Cancer

Clin Cancer Res (2021) 27 (7): 2011–2022.

DOI: https://doi.org/10.1158/1078-0432.CCR-20-3316

Published: 01 April 2021

View article

Includes: Supplementary data

Journal Articles

Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

Clin Cancer Res (2021) 27 (7): 1997–2010.

DOI: https://doi.org/10.1158/1078-0432.CCR-20-3322

Published: 01 April 2021

View article

Includes: Supplementary data

Journal Articles

The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas

Clin Cancer Res (2021) 27 (5): 1516–1525.

DOI: https://doi.org/10.1158/1078-0432.CCR-20-2984

Published: 01 March 2021

View article

Includes: Supplementary data

Journal Articles

Abstract A14: Next-generation sequencing of Bacille Calmette-Guerin (BCG)-unresponsive tumors identifies actionable alterations for potential targeted therapy in non-muscle invasive bladder cancer

Aleksandra Walasek, Nima Almassi, Victor McPherson, Shawn Dason, Nicole Benfante, Tanya Klein, Michael F. Berger, Nikolaus Schultz, Guido Dalbagni, Dean F. Bajorin, Jonathan E. Rosenberg, Hikmat Al-Ahmadie, Bernard H. Bochner, David B. Solit, Gopakumar Iyer, Eugene J. Pietzak

Clin Cancer Res (2020) 26 (15_Supplement): A14.

DOI: https://doi.org/10.1158/1557-3265.BLADDER19-A14

Published: 03 August 2020

View article

Journal Articles

Abstract B20: Characterization of tumor mutational landscape in smokers and nonsmokers with urothelial carcinoma

Aleksandra Walasek, Nima Almassi, Min Yuen Teo, Samuel Funt, Nikolaus Schultz, Guido Dalbagni, Wenhu Hu, Hikmat Al-Ahmadie, Dean F Bajorin, Jonathan E Rosenberg, Gopakumar Iyer, Bernard H. Bochner, David B. Solit, Eugene J. Pietzak

Clin Cancer Res (2020) 26 (15_Supplement): B20.

DOI: https://doi.org/10.1158/1557-3265.BLADDER19-B20

Published: 03 August 2020

View article

Journal Articles

Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing

Martee L. Hensley, Shweta S. Chavan, David B. Solit, Rajmohan Murali, Robert Soslow, Sarah Chiang, Achim A. Jungbluth, Chaitanya Bandlamudi, Preethi Srinivasan, William D. Tap, Evan Rosenbaum, Barry S. Taylor, Mark T.A. Donoghue, David M. Hyman

Clin Cancer Res (2020) 26 (14): 3881–3888.

DOI: https://doi.org/10.1158/1078-0432.CCR-19-3959

Published: 15 July 2020

View article

Includes: Supplementary data

Journal Articles

Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer

Konrad H. Stopsack, Subhiksha Nandakumar, Andreas G. Wibmer, Samuel Haywood, Emily S. Weg, Ethan S. Barnett, Chloe J. Kim, Emily A. Carbone, Samantha E. Vasselman, Bastien Nguyen, Melanie A. Hullings, Howard I. Scher, Michael J. Morris, David B. Solit, Nikolaus Schultz, Philip W. Kantoff, Wassim Abida

Clin Cancer Res (2020) 26 (13): 3230–3238.

DOI: https://doi.org/10.1158/1078-0432.CCR-20-0168

Published: 01 July 2020

View article

Includes: Supplementary data

Journal Articles

Abstract 12: Characterizing KRAS G12C and other mutations in plasma ctDNA from patients with lung cancer

Clin Cancer Res (2020) 26 (12_Supplement_1): 12.

DOI: https://doi.org/10.1158/1557-3265.ADVPRECMED20-12

Published: 15 June 2020

View article

Journal Articles

Overcoming Adaptive Resistance to KRAS Inhibitors Through Vertical Pathway Targeting

Rona Yaeger, David B. Solit

Clin Cancer Res (2020) 26 (7): 1538–1540.

DOI: https://doi.org/10.1158/1078-0432.CCR-19-4060

Published: 01 April 2020

View article

Journal Articles

Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer

Clin Cancer Res (2020) 26 (5): 1077–1085.

DOI: https://doi.org/10.1158/1078-0432.CCR-19-2390

Published: 02 March 2020

View article

Includes: Supplementary data

Journal Articles

Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib

Gary A. Ulaner, Cristina Saura, Sarina A. Piha-Paul, Ingrid Mayer, David Quinn, Komal Jhaveri, Ben Stone, Seta Shahin, Grace Mann, Melanie Dujka, Richard Bryce, Funda Meric-Bernstam, David B. Solit, David M. Hyman

Clin Cancer Res (2019) 25 (24): 7381–7387.

DOI: https://doi.org/10.1158/1078-0432.CCR-19-1658

Published: 13 December 2019

View article

Journal Articles

Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma

Clin Cancer Res (2019) 25 (24): 7475–7484.

DOI: https://doi.org/10.1158/1078-0432.CCR-19-1651

Published: 13 December 2019

View article

Includes: Supplementary data

Journal Articles

Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer

Megan Greally, Joanne F. Chou, Walid K. Chatila, Matthew Margolis, Marinela Capanu, Jaclyn F. Hechtman, Yaelle Tuvy, Ritika Kundra, Foysal Daian, Marc Ladanyi, David P. Kelsen, David H. Ilson, Michael F. Berger, Laura H. Tang, David B. Solit, Luis A. Diaz, Jr, Nikolaus Schultz, Yelena Y. Janjigian, Geoffrey Y. Ku

Clin Cancer Res (2019) 25 (20): 6160–6169.

DOI: https://doi.org/10.1158/1078-0432.CCR-18-3603

Published: 15 October 2019

View article

Includes: Supplementary data

Journal Articles

Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas

Clin Cancer Res (2019) 25 (18): 5537–5547.

DOI: https://doi.org/10.1158/1078-0432.CCR-19-0032

Published: 13 September 2019

View article

Includes: Supplementary data

Journal Articles

Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer

Clin Cancer Res (2019) 25 (13): 3811–3817.

DOI: https://doi.org/10.1158/1078-0432.CCR-18-3789

Published: 01 July 2019

View article

Includes: Supplementary data

2 3

NARROW

The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma

Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors

Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer

Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways

Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas

Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial Cancer

Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas

Abstract A14: Next-generation sequencing of Bacille Calmette-Guerin (BCG)-unresponsive tumors identifies actionable alterations for potential targeted therapy in non-muscle invasive bladder cancer

Abstract B20: Characterization of tumor mutational landscape in smokers and nonsmokers with urothelial carcinoma

Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing

Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer

Abstract 12: Characterizing KRAS G12C and other mutations in plasma ctDNA from patients with lung cancer

Overcoming Adaptive Resistance to KRAS Inhibitors Through Vertical Pathway Targeting

Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer

Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib

Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma

Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer

Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas

Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only